A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
January 2025 — Vol. 2, No. 1
Page 3 of 4 of this archive, newest first.
Also filed — page 3
the rolling newsroom, January 2025The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
What a 32% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Medutest result on a Nantong semaglutide lot lands 3.0 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
From the floor in Zhuhai: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Independent analysis puts a QSC exenatide lot at 97.5%, against 96.7% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
New Zealand pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The consolidator trading as Meridian Freight Partners enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
SURMOUNT-4 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
TFC declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Calder Vale Peptides of Skipton closes after 12 years
A proper account of an operation that existed, and of what closing it cost.
Spain health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
SURPASS-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What changed at GL Biochem in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Spain guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 32% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
South Africa caps tirzepatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A supplier suspends shipping to New Zealand after 3 consecutive customs detentions
The route did not close because of a rule about peptides.
FGP declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Japan declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite Halvard & Pike Apothecary of Portland, Maine over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new Nigeria guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The consolidator trading as Meridian Freight Partners closes after 21 years
A proper account of an operation that existed, and of what closing it cost.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.